Three Considerations while Navigating Agentic AI Implementation in GMP Manufacturing
As manufacturers adopt artificial intelligence solutions to enhance efficiency and reduce costs, agentic AI systems present both remarkable opportunities and unique regulatory considerations. There are three key areas manufacturers should consider in order to harness the power of AI while maintaining the quality, safety, and compliance standards that are essential to GMP operations.
Don’t Settle for a Landline: Cloud-Native SaaS for MES
It’s time to ditch outdated architecture. You wouldn’t settle for a landline in this day and age, so why would you stay with an on-prem MES provider retrofitting to the cloud when you could go cloud-native?
Next-Gen MES Revealed: Separating Substance from Buzz
Next-Gen MES is often thrown around as a buzzword, but what does it really mean? Watch "Next-Gen MES Revealed: Separating Substance from Buzz" with Emilee Cook, Director of Product. We begin by clarifying what a next-gen MES is not, debunking common misconceptions.
Cloud Migration: 10 Questions to Ask Your MES Vendor
Is your MES vendor moving to the cloud? From downtime to integrations, learn the top 10 questions to ask to understand its full impact on your operations.
What are the most common pitfalls faced by pharmaceutical manufacturers today? Better yet, how can you avoid them and mitigate risk across the board? All this and more inside.
How to Accelerate Your Product Pipeline with a Connected Manufacturing Network
Apprentice CEO and co-founder Angelo Stracquatanio provides actionable recommendations on how to use technology to create a connected manufacturing network.
Pharma 4.0: What It Means and What It Offers for CGT
The future of medicine is here, and it's powered by Pharma 4.0. Find out how cutting-edge technology is making it possible to treat diseases like never before.
Our validation experts, Michael Martone and Andrew Benjamin, show you how to navigate the changing regulatory landscape, and discuss why organizations are now turning to Quality not just for compliance, but as a source of innovation.
Cell and Gene Therapies: Roadblocks & Opportunities
From the promise of personalized medicine to the complexities of gene editing, the world of cell and gene therapies is rapidly evolving. Join us as we delve into the latest research on these cutting-edge treatments, analyzing the key obstacles and opportunities shaping their trajectory.
The Future Role of AI in Pharma Manufacturing Post Discovery Phase
We talk about the process from preclinical development to full commercial supply and identify some use cases for people struggling with where they can start with their AI journey.
Cell therapy and gene therapy: how are they similar, how are they different, and how do they work? Better yet: how are they changing the future of medicine? Frank Maggiore, Chief Futurist at Apprentice, is excited about the possibilities.
Software Validation in Pharma: Here’s How We Do It
Pharmaceutical software validation got you down? We’ve got you covered. Here’s how Apprentice makes the validation process easier while saving you time and money.
Our pharma manufacturing systems expert, Keith Bowen, shares 10 disruptive trends shaping the future of life science manufacturing, and how you can adapt to stay on target and ahead of the curve.
63% of pharma companies are missing out on the power of digital technologies to streamline their workflows, reduce errors, and accelerate time to market. In this article, we’ll walk you through top challenges and roadblocks, along with incremental ways to step into the digital age and take advantage of all the benefits it offers.
Learn 10 disruptive trends shaping the future of pharma, and how you can adapt to stay on target and ahead of the curve. Read the full eBook to learn more.
Your Guide to Modernizing Commercial Drug Manufacturing
Digital transformation in commercial pharma is making it easier to bring new drugs to market sooner. In this article, we’ll explore how to modernize commercial drug manufacturing.